Plain-English translation of NCT06845644 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study uses a special type of MRI scan called quantitative neuromuscular MRI to measure how nerve damage affects muscles over time. Researchers are looking at three types of nerve diseases: Charcot-Marie-Tooth neuropathy (an inherited condition), hereditary transthyretin amyloid neuropathy (another inherited nerve disease), and acquired demyelinating neuropathy (a nerve disease that develops later in life). The MRI scans can detect fatty changes in muscle tissue and other signs of nerve damage more accurately than current tests.
Current clinical tests are not sensitive enough to detect early signs of nerve disease or to measure whether new treatments are working. This research aims to develop better ways to track disease progression and monitor treatment response using MRI imaging, which could help speed up the development of new therapies.
You likely qualify if…
You likely don't qualify if…
Participants will undergo repeated MRI scans of their legs and arms at scheduled visits to measure changes in nerve and muscle tissue over time. The study will enroll 120 people across three groups based on their type of neuropathy. The MRI is a non-invasive imaging procedure that uses magnetic fields rather than radiation to create detailed pictures of your muscles and nerves.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
France